Clinical Trials Browser

Phase 2 × Not yet recruiting × Biosimilar Pharmaceuticals × Clear all

NCT07246317 2025-11-28

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07220135 2025-10-23

NeoTHERa

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06650709 2024-10-23

NEOCATS

Phase 2 Not yet recruiting

Ovarian Neoplasms